Fresenius Medical Care AG & Co. KGaA (ETR:FME) Stock Price Breaks Below the 200-Day Moving Average of $56.89

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) broke below its 200-day moving average during Monday’s session. The stock has a two-hundred-day moving average of €56.89 ($56.89) and is trading as low as €46.59 ($46.59). Shares of Fresenius Medical Care AG & Co. KGaA last traded at €47.60 ($47.60), with a volume of 767,504 shares traded.

FME has been the subject of several research analyst reports. Warburg Research set a price target of €62.00 ($62.00) on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, May 10. Berenberg Bank set a price target of €82.20 ($82.20) on shares of Fresenius Medical Care AG & Co. KGaA in a Monday, June 27 research report. Deutsche Bank Rese… set a price target of €58.00 ($58.00) on shares of Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research report. Deutsche Bank Aktiengesellschaft set a price target of €58.00 ($58.00) on shares of Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 report. Finally, Goldman Sachs Group set a price target of €71.00 ($71.00) on shares of Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 report.

The company has a market capitalization of $13.75 billion and a P/E ratio of 15.76. The company has a debt ratio of 91.78, a current ratio of 1.26 and a quick ratio of 0.79. The stock’s 50-day simple moving average is €52.89 and its two-hundred-day simple moving average is €56.89.

About Fresenius Medical Care AG & Co. KGaA (ETR: FME)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured Articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.